Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patientsTheodore J. Cicero, Peter W. Park, Mario Mendoza et al.|Postgraduate Medicine|2019Cited by 8
REAL-WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG UNTREATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS AND THOSE INITIATING APIXABAN, DABIGATRAN, RIVAROXABAN, OR WARFARINAlpesh Amin, Jeffrey Trocio, Shalabh Singhal et al.|Journal of the American College of Cardiology|2016Cited by 2
TREATMENT AND DISCHARGE PATTERNS AMONG PATIENTS HOSPITALIZED WITH NON-VALVULAR ATRIAL FIBRILLATION WHO TRANSITION FROM THE INPATIENT TO OUTPATIENT SETTINGHenry J. Henk, Lien Vo, Kenneth Tuell et al.|Journal of the American College of Cardiology|2016Cited by 0
Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarinAlpesh Amin, Jeffrey Trocio, Allison Keshishian et al.|MEF University Institutional Repository (MEF University)|2016Cited by 0